OVID
Ovid Therapeutics Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Ovid Therapeutics (OVID) Stock: Buy, Sell, or Hold?
$2.54
-0.01 (-0.39%)
▼
5d:
-10.88%
30d:
+12.39%
90d:
-12.11%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
45/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$2.23 – $2.64
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-6.3x
Next 12M consensus est.
Wall Street Target
$6.15
+142.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.33 / $3.09
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: OVID is down 10.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When OVID Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: OVID is currently trading at $2.54, which is considered slightly high relative to its 30-day fair value range of $2.23 to $2.64.
Technical Outlook: Technically, OVID is in a strong uptrend. Immediate support is located at $2.33, while resistance sits at $3.09.
Market Sentiment: OVID scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.15 (+142.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OVID is in a strong uptrend. Immediate support is located at $2.33, while resistance sits at $3.09.
Market Sentiment: OVID scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.15 (+142.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.23 -
$2.64
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
Trading Range & Key Levels
30-Day Trading Range
$2.23 -
$2.64
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$2.33
Resistance Level
$3.09
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 142.1% below Wall St target ($6.15)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-6.32
Wall Street Target
$6.15
(+142.1%)
Revenue Growth (YoY)
-88.3%
Share OVID Analysis
Share this live OVID analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (OVID)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits identifies resistance levels at $2.07 and $2.10 for $OVID stock. He believes breaking through these levels could lead to potential upside targets at $3.39, $3.65, and $3.97.
Key Retail Themes:
Resistance levels
Upside potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:20 PM ET
Data refreshes hourly during market hours. Next update: 6:20 PM
Data refreshes hourly during market hours. Next update: 6:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OVID showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 43 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive OVID Research Pages
